<em>De novo</em> 3q13.13q21.2 interstitial deletion and paternal 12p13.3 microdeletion in a fetus with dysplasia of the corpus callosum and ventriculomegaly: A case report

Libotte,Francesco; Fabiani,Marco; Margiotti,Katia; Carpineto,Lorena Sonia; Monaco,Francesca; Raffio,Raffaella; Mesoraca,Alvaro; Giorlandino,Claudio

doi:10.3892/etm.2023.11799

February-2023 Volume 25 Issue 2

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

February-2023 Volume 25 Issue 2

Full Size Image

Case Report Open Access

De novo 3q13.13q21.2 interstitial deletion and paternal 12p13.3 microdeletion in a fetus with dysplasia of the corpus callosum and ventriculomegaly: A case report

Authors:
- Francesco Libotte
- Marco Fabiani
- Katia Margiotti
- Lorena Sonia Carpineto
- Francesca Monaco
- Raffaella Raffio
- Alvaro Mesoraca
- Claudio Giorlandino
View Affiliations / Copyright

Affiliations: Human Genetics Laboratory, Fetal‑Maternal Medical Centre, ALTAMEDICA, 00198 Rome, Italy

Copyright: © Libotte et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
Article Number: 100
|
Published online on: January 16, 2023

https://doi.org/10.3892/etm.2023.11799
Expand metrics +

Abstract

Chromosome 3q syndrome is a well‑known genetic condition caused by interstitial deletion in the long arm of chromosome 3. The phenotype of this syndrome is variable and the great variability in the extent of these deletions leads to a wide spectrum of clinical manifestations. Terminal 12p deletion represents one of the rarest subtelomeric imbalances; patients with distal monosomy 12p present different phenotypes ranging from muscular hypotonia to autism spectrum disorders. The present study reported a prenatal diagnosis of a male fetus presenting ultrasound evidence of corpus callosum dysplasia and ventriculomegaly showing a 3q13q21.2 deletion and a 12p13.33 microdeletion paternally inherited. Among several features previously attributed to the terminal deletion of 3q, corpus callosum dysplasia and ventriculomegaly have rarely been reported together. As the 12p13.33 microdeletion in the father was associated only with muscular hypotonia and joint laxity, the involvement of terminal 12p deletions in the clinical features of the fetus was not possible to verify during the prenatal period. The present case report may provide a reference for prenatal diagnosis and genetic counseling in patients who present 3q13q21.2 deletions and 12p13.33 microdeletion.

View Figures

View References

1	Ramieri V, Tarani L, Costantino F, Basile E, Liberati N, Rinna C, Cascone P and Colloridi F: Microdeletion 3q syndrome. J Craniofac Surg. 22:2124–2128. 2011.PubMed/NCBI View Article : Google Scholar
2	Molin AM, Andrieux J, Koolen DA, Malan V, Carella M, Colleaux L, Cormier-Daire V, David A, de Leeuw N, Delobel B, et al: A novel microdeletion syndrome at 3q13.31 characterised by developmental delay, postnatal overgrowth, hypoplastic male genitals, and characteristic facial features. J Med Genet. 49:104–109. 2012.PubMed/NCBI View Article : Google Scholar
3	Tanaka-Arakawa MM, Matsui M, Tanaka C, Uematsu A, Uda S, Miura K, Sakai T and Noguchi K: Developmental changes in the corpus callosum from infancy to early adulthood: A structural magnetic resonance imaging study. PLoS One. 10(e0118760)2015.PubMed/NCBI View Article : Google Scholar
4	Hofman J, Hutny M, Sztuba K and Paprocka J: Corpus callosum agenesis: An insight into the etiology and spectrum of symptoms. Brain Sci. 10(625)2020.PubMed/NCBI View Article : Google Scholar
5	Hanna RM, Marsh SE, Swistun D, Al-Gazali L, Zaki MS, Abdel-Salam GM, Al-Tawari A, Bastaki L, Kayserili H, Rajab A, et al: Distinguishing 3 classes of corpus callosal abnormalities in consanguineous families. Neurology. 76:373–382. 2011.PubMed/NCBI View Article : Google Scholar
6	Edwards TJ, Sherr EH, Barkovich AJ and Richards LJ: Clinical, genetic and imaging findings identify new causes for corpus callosum development syndromes. Brain. 137:1579–1613. 2014.PubMed/NCBI View Article : Google Scholar
7	Raybaud C: The corpus callosum, the other great forebrain commissures, and the septum pellucidum: Anatomy, development, and malformation. Neuroradiology. 52:447–477. 2010.PubMed/NCBI View Article : Google Scholar
8	Libotte F, Fabiani M, Margiotti K, Viola A, Mesoraca A and Giorlandino C: Prenatal diagnosis of combined maternal 4q interstitial deletion and paternal 15q microduplication. Genes (Basel). 12(1626)2021.PubMed/NCBI View Article : Google Scholar
9	Pilu G and Hobbins JC: Sonography of fetal cerebrospinal anomalies. Prenat Diagn. 22:321–330. 2002.PubMed/NCBI View Article : Google Scholar
10	Wang J, Zhang Z, Li Q, Zhu H, Lai Y, Luo W, Liu S, Wang H and Hu T: Prenatal diagnosis of chromosomal aberrations by chromosomal microarray analysis in foetuses with ventriculomegaly. Sci Rep. 10(20765)2020.PubMed/NCBI View Article : Google Scholar
11	Griffiths PD, Reeves MJ, Morris JE, Mason G, Russell SA, Paley MN and Whitby EH: A prospective study of fetuses with isolated ventriculomegaly investigated by antenatal sonography and in utero MR imaging. AJNR Am J Neuroradiol. 31:106–111. 2010.PubMed/NCBI View Article : Google Scholar
12	Alluhaybi AA, Altuhaini K and Ahmad M: Fetal ventriculomegaly: A review of literature. Cureus. 14(e22352)2022.PubMed/NCBI View Article : Google Scholar
13	Ravnan JB, Tepperberg JH, Papenhausen P, Lamb AN, Hedrick J, Eash D, Ledbetter DH and Martin CL: Subtelomere FISH analysis of 11 688 cases: An evaluation of the frequency and pattern of subtelomere rearrangements in individuals with developmental disabilities. J Med Genet. 43:478–489. 2006.PubMed/NCBI View Article : Google Scholar
14	Firth HV, Richards SM, Bevan AP, Clayton S, Corpas M, Rajan D, Van Vooren S, Moreau Y, Pettett RM and Carter NP: DECIPHER: Database of chromosomal imbalance and phenotype in humans using ensembl resources. Am J Hum Genet. 84:524–533. 2009.PubMed/NCBI View Article : Google Scholar
15	Mirzaa G, Parry DA, Fry AE, Giamanco KA, Schwartzentruber J, Vanstone M, Logan CV, Roberts N, Johnson CA, Singh S, et al: De novo CCND2 mutations leading to stabilization of cyclin D2 cause megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome. Nat Genet. 46:510–515. 2014.PubMed/NCBI View Article : Google Scholar
16	Ozcelik T, Rosenthal A and Francke U: Chromosomal mapping of brain-derived neurotrophic factor and neurotrophin-3 genes in man and mouse. Genomics. 10:569–575. 1991.PubMed/NCBI View Article : Google Scholar
17	Awad S, Al-Dosari MS, Al-Yacoub N, Colak D, Salih MA, Alkuraya FS and Poizat C: Mutation in PHC1 implicates chromatin remodeling in primary microcephaly pathogenesis. Hum Mol Genet. 22:2200–2213. 2013.PubMed/NCBI View Article : Google Scholar
18	Nagao M, Ogata T, Sawada Y and Gotoh Y: Zbtb20 promotes astrocytogenesis during neocortical development. Nat Commun. 7(11102)2016.PubMed/NCBI View Article : Google Scholar
19	Nielsen JV, Thomassen M, Mollgard K, Noraberg J and Jensen NA: Zbtb20 defines a hippocampal neuronal identity through direct repression of genes that control projection neuron development in the isocortex. Cereb Cortex. 24:1216–1229. 2014.PubMed/NCBI View Article : Google Scholar
20	Xie Z, Ma X, Ji W, Zhou G, Lu Y, Xiang Z, Wang YX, Zhang L, Hu Y, Ding YQ and Zhang WJ: Zbtb20 is essential for the specification of CA1 field identity in the developing hippocampus. Proc Natl Acad Sci USA. 107:6510–6515. 2010.PubMed/NCBI View Article : Google Scholar
21	Sokoloff P, Giros B, Martres MP, Bouthenet ML and Schwartz JC: Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics. Nature. 347:146–151. 1990.PubMed/NCBI View Article : Google Scholar
22	Leyser M, Dias BL, Coelho AL, Vasconcelos M and Nascimento OJ: 12p deletion spectrum syndrome: A new case report reinforces the evidence regarding the potential relationship to autism spectrum disorder and related developmental impairments. Mol Cytogenet. 9(75)2016.PubMed/NCBI View Article : Google Scholar
23	Fanizza I, Bertuzzo S, Beri S, Scalera E, Massagli A, Sali ME, Giorda R and Bonaglia MC: Genotype-phenotype relationship in a child with 2.3 Mb de novo interstitial 12p13.33-p13.32 deletion. Eur J Med Genet. 57:334–338. 2014.PubMed/NCBI View Article : Google Scholar
24	Rincic M, Rados M, Kopic J, Krsnik Z and Liehr T: 7p21.3 together with a 12p13.32 deletion in a patient with microcephaly-does 12p13.32 locus possibly comprises a candidate gene region for microcephaly? Front Mol Neurosci. 14(613091)2021.PubMed/NCBI View Article : Google Scholar
25	Thevenon J, Callier P, Andrieux J, Delobel B, David A, Sukno S, Minot D, Mosca Anne L, Marle N, Sanlaville D, et al: 12p13.33 microdeletion including ELKS/ERC1, a new locus associated with childhood apraxia of speech. Eur J Hum Genet. 21:82–88. 2013.PubMed/NCBI View Article : Google Scholar
26	El Hayek L, Tuncay IO, Nijem N, Russell J, Ludwig S, Kaur K, Li X, Anderton P, Tang M, Gerard A, et al: KDM5A mutations identified in autism spectrum disorder using forward genetics. Elife. 9(e56883)2020.PubMed/NCBI View Article : Google Scholar
27	Silva IM, Rosenfeld J, Antoniuk SA, Raskin S and Sotomaior VS: A 1.5Mb terminal deletion of 12p associated with autism spectrum disorder. Gene. 542:83–86. 2014.PubMed/NCBI View Article : Google Scholar
28	Han JY and Park J: Variable phenotypes of epilepsy, intellectual disability, and schizophrenia caused by 12p13.33-p13.32 terminal microdeletion in a korean family: A case report and literature review. Genes (Basel). 12(1001)2021.PubMed/NCBI View Article : Google Scholar
29	Rodan AR and Jenny A: WNK kinases in development and disease. Curr Top Dev Biol. 123:1–47. 2017.PubMed/NCBI View Article : Google Scholar
30	Luderman LN, Michaels MT, Levic DS and Knapik EW: Zebrafish Erc1b mediates motor innervation and organization of craniofacial muscles in control of jaw movement. Dev Dyn: Jun 16, 2022 (Epub Ahead of Print).